216 related articles for article (PubMed ID: 3356357)
1. Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial.
Humphreys H; Bourke S; Dooley C; McKenna D; Power B; Keane CT; Sweeney EC; O'Moráin C
Gut; 1988 Mar; 29(3):279-83. PubMed ID: 3356357
[TBL] [Abstract][Full Text] [Related]
2. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.
Marshall BJ; Goodwin CS; Warren JR; Murray R; Blincow ED; Blackbourn SJ; Phillips M; Waters TE; Sanderson CR
Lancet; 1988 Dec 24-31; 2(8626-8627):1437-42. PubMed ID: 2904568
[TBL] [Abstract][Full Text] [Related]
3. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer.
Eberhardt R; Kasper G
Rev Infect Dis; 1990; 12 Suppl 1():S115-9. PubMed ID: 2406852
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Rösch W
Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
[TBL] [Abstract][Full Text] [Related]
6. Bismuth: effects on gastritis and peptic ulcer.
Rokkas T; Sladen GE
Scand J Gastroenterol Suppl; 1988; 142():82-6. PubMed ID: 3047853
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
8. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.
Goodwin CS; Marshall BJ; Blincow ED; Wilson DH; Blackbourn S; Phillips M
J Clin Pathol; 1988 Feb; 41(2):207-10. PubMed ID: 3280609
[TBL] [Abstract][Full Text] [Related]
9. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Wagstaff AJ; Benfield P; Monk JP
Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
[TBL] [Abstract][Full Text] [Related]
10. Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine.
Borkent MV; Beker JA
Gut; 1988 Mar; 29(3):385-9. PubMed ID: 3281872
[TBL] [Abstract][Full Text] [Related]
11. [Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
Eberhardt R; Kasper G; Dettmer A; Höchter W; Hagena D
Med Klin (Munich); 1988 May; 83(12):402-5. PubMed ID: 3043160
[No Abstract] [Full Text] [Related]
12. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
Morris A; Brown P; Ali MR; Lane M; Palmer R
N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
Drumm B; Sherman P; Chiasson D; Karmali M; Cutz E
J Pediatr; 1988 Nov; 113(5):908-12. PubMed ID: 3183851
[TBL] [Abstract][Full Text] [Related]
14. Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori.
Hui WM; Lam SK; Ho J; Ng I; Lau WY; Branicki FJ; Lai CL; Lok AS; Ng MM; Fok J
Am J Med; 1989 Jun; 86(6A):60-5. PubMed ID: 2660558
[TBL] [Abstract][Full Text] [Related]
15. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate.
Loffeld RJ; Potters HV; Stobberingh E; Flendrig JA; van Spreeuwel JP; Arends JW
Gut; 1989 Sep; 30(9):1206-12. PubMed ID: 2680795
[TBL] [Abstract][Full Text] [Related]
16. Campylobacter pylori and ulcer disease--a causal connection?
Wormsley KG
Scand J Gastroenterol Suppl; 1989; 160():53-8. PubMed ID: 2683023
[TBL] [Abstract][Full Text] [Related]
17. Campylobacter pylori: its link to gastritis and peptic ulcer disease.
Marshall BJ
Rev Infect Dis; 1990; 12 Suppl 1():S87-93. PubMed ID: 2406862
[TBL] [Abstract][Full Text] [Related]
18. Campylobacter pylori in Saudi patients undergoing upper gastrointestinal endoscopy: prevalence and effect of conventional therapy.
al-Freihi HM; al-Qurain A; al-Gindan Y; Ibrahim EM; Satti MB; Twum-Danso K; al-Idrissi HY; al-Ghassab G; al-Hamdan A
Hepatogastroenterology; 1989 Dec; 36(6):516-8. PubMed ID: 2613174
[TBL] [Abstract][Full Text] [Related]
19. Campylobacter pylori and its role in peptic ulcer disease.
Tytgat GN; Rauws EA
Gastroenterol Clin North Am; 1990 Mar; 19(1):183-96. PubMed ID: 2184128
[TBL] [Abstract][Full Text] [Related]
20. [Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
Rühl GH; Börsch G
Pathologe; 1989 Jan; 10(1):64-5. PubMed ID: 2922381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
